Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist approved to control blood sugar levels in people with type 2 diabetes, along with diet and exercise, among other uses
However, it is associated with significant incidences of infusion reactions, anaphylaxis, methemoglobinemia, and hemolysis, particularly in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency
Nakamura Y, et al
NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macrophages [PMID: 24824795] Laboratory literature summary: NAMPT-mediated salvage synthesis of NAD+ controls morphofunctional changes of macrophages
Mechanistically, it works upstream of structural damage by blocking NF-kappaB before the downstream cytokine cascade (TNF-alpha, IL-1beta, IL-6) gets going, rather than mopping up inflammation after the fact